Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

VK2735 for Weight Management Phase 2

Phase: N/A Priority: Normal
NCT ID: NCT06068946 Org: User:
Start: 08/31/23 End: 04/02/24 Due: 04/02/25

Phase 1 Study to Evaluate the Safety and Tolerability of VK2735

Phase: N/A Priority: Normal
NCT ID: NCT05203237 Org: User:
Start: 12/14/21 End: 12/03/24 Due: 12/03/25

Acute Hip Fracture Study in Patients 65 Years or Greater

Phase: N/A Priority: Normal
NCT ID: NCT02578095 Org: User:
Start: 10/30/15 End: 03/31/18 Due: 03/31/19

Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT02927184 Org: User:
Start: 09/28/16 End: 03/26/19 Due: 03/26/20

A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN

Phase: N/A Priority: Normal
NCT ID: NCT04973657 Org: User:
Start: 06/22/21 End: 11/08/24 Due: 11/08/25

VK2735 for Weight Management Phase 2 (Venture Oral Dosing)

Phase: N/A Priority: Normal
NCT ID: NCT06828055 Org: User:
Start: 12/18/24 End: 11/30/25 Due: 11/30/26

A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH

Phase: N/A Priority: Normal
NCT ID: NCT04173065 Org: User:
Start: 11/15/19 End: 01/26/24 Due: 01/26/25